| For the treatment of dilutional hyponatremia – SAMSCA [tolvaptan] | |
| Vasopressin receptor antagonist which increases serum sodium levels through increase in free water clearance. See Full Safety and Prescribing Information, including Boxed Warning. | |
| Keywords : Samsca, tolvaptan, hyponatremia treatment, serum sodium, water clearance, mechanism of action, MOA | |
| H2 tags : Please enter your information below to receive the Serum Sodium Sentinel, which includes important updates about hyponatremia and the latest news on SAMSCA. |
| Last Update : | 02/January/2012 |
| Google PR : | N/A |
| Internal links : | 19 |
| External links : | 1 |
| Archive : | Check how did the site look in the past? |